- Home
- NMRA vs EVC Comparison
NMRA vs EVC Comparison
Compare NMRA & EVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NMRA
- EVC
- Stock Information
- Founded
- NMRA 2019
- EVC 1996
- Country
- NMRA United States
- EVC United States
- Employees
- NMRA N/A
- EVC N/A
- Industry
- NMRA
- EVC Broadcasting
- Sector
- NMRA
- EVC Industrials
- Exchange
- NMRA Nasdaq
- EVC Nasdaq
- Market Cap
- NMRA 268.5M
- EVC 226.5M
- IPO Year
- NMRA 2023
- EVC 2000
- Fundamental
- Price
- NMRA $1.62
- EVC $2.48
- Analyst Decision
- NMRA Buy
- EVC
- Analyst Count
- NMRA 8
- EVC 0
- Target Price
- NMRA $7.14
- EVC N/A
- AVG Volume (30 Days)
- NMRA 383.3K
- EVC 205.3K
- Earning Date
- NMRA 11-11-2025
- EVC 11-05-2025
- Dividend Yield
- NMRA N/A
- EVC 8.13%
- EPS Growth
- NMRA N/A
- EVC N/A
- EPS
- NMRA N/A
- EVC N/A
- Revenue
- NMRA N/A
- EVC $396,704,000.00
- Revenue This Year
- NMRA N/A
- EVC $64.06
- Revenue Next Year
- NMRA N/A
- EVC N/A
- P/E Ratio
- NMRA N/A
- EVC N/A
- Revenue Growth
- NMRA N/A
- EVC 25.34
- 52 Week Low
- NMRA $0.61
- EVC $1.58
- 52 Week High
- NMRA $17.19
- EVC $2.73
- Technical
- Relative Strength Index (RSI)
- NMRA 47.71
- EVC 52.15
- Support Level
- NMRA $1.60
- EVC $2.27
- Resistance Level
- NMRA $1.70
- EVC $2.51
- Average True Range (ATR)
- NMRA 0.09
- EVC 0.09
- MACD
- NMRA -0.01
- EVC -0.01
- Stochastic Oscillator
- NMRA 8.51
- EVC 63.64
About NMRA Neumora Therapeutics Inc.
Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.